The Hospital Gold Standard Catches Just 5% of Arrhythmias with Vlastimil Hrabal

In this episode, your host, Jordan Burgin, is joined by Vlastimil Hrabal, CEO and Co-Founder of Kardi AI, to unpack why a 24-hour Holter monitor the hospital gold standard misses most dangerous arrhythmias, and how long-term, AI-evaluated ECG monitoring is changing detection, prevention, and the economics of cardiac care. Key Topics Why long-term ECG monitoring outperforms the 24-hour Holter standard Building two AI models one to detect arrhythmias, one to strip out noise and artifacts Earning clinician trust through MDR Class IIa certification and university-hospital studies A three-channel commercial model: hospitals, direct-to-consumer, and employee benefits Scaling a regulated device across Central Europe, India, the Gulf and Southeast Asia Raising a Series A in a tougher, more data-hungry healthcare capital market Related Insights Why roughly half of arrhythmia patients are asymptomatic and what that means for screening How AI can act as a “third eye” for cardiologists rather than replacing them What sustained patient “stickiness” (four measurements a week, over years) reveals about real-world value Localising a regulated medical device market by market pricing, partners and presence Core Challenges A 24-hour Holter monitor detects an arrhythmia in only ~3–5% of cases, because dangerous rhythms such as atrial fibrillation appear unpredictably and are easily missed in a single day’s snapshot while patients can wait three to six months for testing and weeks more for results. Kardi AI’s certified, wearable long-term ECG belt lets patients measure anytime, with AI-evaluated reports returned within five minutes to both patient and physician reportedly a 10× higher detection rate, while reducing clinician workload and false positives. 🎧 Tune in now to hear why the future of cardiac care is continuous, AI-evaluated, and built for prevention not just diagnosis.